Fitesa introduces silver ion-based surface treatment for coronavirus; verified effective within 15 minutes of contact


Medical worker with protective apparel
The Fitesa Shield product line consists of antimicrobial spunbond and multi-layer SMS that can be used in various applications such as the production of surgical gowns and drapes, sterilization wraps, head covers, shoe covers, facemasks and respirators, among others. Photo: iStock/Feverpitched

Following a series of investments to support the fight against the COVID-19 pandemic, Fitesa announces the expansion of its antimicrobial product line with a material that inactivates 99% of coronavirus within 15 minutes of contact. By the end of 30 minutes, the tested sample showed 99.9% of the virus inactivated. Tests were conducted by UNICAMP in November 2020 with the MHV strain of coronavirus, the same genus and family of SARS-CoV-2 (originator of COVID-19), SARS-CoV-1 and MERS.

Fitesa Shield AV nonwovens have silver ions in its structure. The process technology secures a lasting effect throughout the product’s lifecycle. The treatment is non-toxic, meets FDA and European Union requirements and does not impact any other physical or chemical product properties.

The Fitesa Shield product line consists of antimicrobial spunbond and multi-layer SMS that can be used in various applications such as the production of surgical gowns and drapes, sterilization
wraps, head covers, shoe covers, bed linen and laminates, including important respiratory protection equipment like N95 facemasks and respirators, among others.

fitesa.com